Seegene Technologies is advancing molecular diagnostic tests for a pandemic-proof world. From infectious diseases, women’s health to personalized medicine, all are fuelled by access to rapid and multiplexed diagnostic tools. Seegene has established a comprehensive suite of molecular diagnostics solutions including various multiplex MDx assays, an all-in-one platform for nucleic acid extraction from primary specimens to their proprietary software for automated and efficient data analysis. This helps researchers increase laboratory throughput and cost effectiveness.

Seegene Technologies

Vaccination can help reduce transmission of 𝘉𝘰𝘳𝘥𝘦𝘵𝘦𝘭𝘭𝘢 𝘗𝘦𝘳𝘵𝘶𝘴𝘴𝘪𝘴, but immunity may weaken over time after childhood vaccination, increasing the risk of re-infection.
Whooping cough is highly contagious, especially among infants, young children, and individuals with weakened immune systems, and it spreads easily within families.
The early symptoms of whooping cough are similar to those of a cold or other respiratory illnesses, making accurate diagnosis challenging.
Diagnosis through MDx is essential for early identification, timely treatment, and effective infection control.

#Globalhealth #Bacterialinfection #Pertussis #Atypicalbacterium #Pneumonia #MDx

The global outbreak of bacterial respiratory infections has led to significant changes worldwide.
In response, many countries have updated their guidelines for the 2023-2024 winter season, with a stronger emphasis on surveillance of respiratory bacterial infections.
These updates include increased recommendations for the use of molecular diagnostic (MDx) tests to combat the rising incidence and spread of respiratory diseases.
𝘔𝘺𝘤𝘰𝘱𝘭𝘢𝘴𝘮𝘢 𝘱𝘯𝘦𝘶𝘮𝘰𝘯𝘪𝘢𝘦, which often presents similar symptoms to viral infections, highlights the need for accurate diagnosis.
Testing for bacterial infections, including 𝘔𝘺𝘤𝘰𝘱𝘭𝘢𝘴𝘮𝘢 𝘱𝘯𝘦𝘶𝘮𝘰𝘯𝘪𝘢𝘦, is crucial for early identification, timely treatment, and effective infection control.
#Globalhealth #Bacterialinfection #Mycoplasma #Atypicalbacterium #Pneumonia #MDx

Seegene Technologies, Inc. Announces Name Change to Seegene USA, Inc. - GlobeNewswire

Seegene names Dr. Glen Hansen as head of medical affairs of its US subsidiary - 매일경제

Announcing Seegene OneSystem, a global collaboration to advance syndromic PCR assays - Nature.com

👀 https://bit.ly/3DGx2l7

From testing pathogen by pathogen to testing in a single tube.
Our Open Innovation Program winners explain #syndromic qPCR testing and how it can revolutionize diagnostics.

#Seegene #SpringerNature #syndromicqPCR #MolecularDiagnostics #MDx #OpenInnovationProgram

Top 10 startups in In Vitro Diagnostics in South Korea in Nov, 2024 - Tracxn

Cancer Biomarkers Market Size, Share | CAGR Of 12.5% - Market.us

Four Benefits of Multiplex Technology for Patients - MPO-mag

🎥 https://bit.ly/41VtyVY 

This past October, we had the privilege of hosting an awards ceremony for eight Open Innovation Program (OIP) winners at Springer Nature's London campus.
Check out the video to learn how Seegene is making a significant impact on public health, particularly among underrepresented groups.

#Seegene #SpringerNature #syndromicqPCR #MolecularDiagnostics #MDx #OpenInnovationProgram

Life-sciences real estate developer HatchSpaces opens lab facility in Orange County - The Business Journals

Viral or bacterial pneumonia? Stop the guesswork!
Bacteria are a major cause of pneumonia, but viruses can also cause it.
Viral and bacterial infections can interact in various ways, increasing the complexity of respiratory infections.
This makes accurate diagnosis crucial because the right diagnosis leads to the right treatment.
Seegene's syndromic testing can solve this complex puzzle by looking at all the clues at once.
#SyndromicTesting #Respiratoryinfection #Seegene #PCR

Groundbreaking PCR technology to halt the spread of disease - Nature.com

✨ https://bit.ly/41KE56G
We're thrilled to share our new article written in partnership with Springer Nature.
In this new piece, you can get a sneak peek into how two of our #OIP (Open Innovation Program) awardees, hand in hand with Seegene, plan to contribute to improving women's health through the use of #syndromic qPCR testing. 

#Seegene #WomensHealth #MolecularDiagnostics #MDx #SyndromicqPCR #OpenInnovationProgram #STIs #BrandedContent

🌍 December 27 marks the International Day of Epidemic Preparedness, a day to reflect on the importance of preventing and preparing for global health crises.
Epidemics can disrupt lives, economies, and entire nations, highlighting the urgent need for robust health systems, global collaboration, and innovative solutions.

Seegene envisions a world free from all diseases.
On this important day, we stand with the global community in emphasizing the value of awareness, preparedness, and solidarity to safeguard public health.
Let’s work together to build a safer and healthier future for everyone.

#Seegene #EpidemicPreparedness #HealthForAll #GlobalHealth #PreventEpidemics

👏🏼 Thank you all so much for your interest in Nature Awards MDx Impact Grants, our awards program held in partnership with Springer Nature. The application period has now closed, but we are deeply impressed by the global response and the innovative proposals submitted. Your commitment to advancing syndromic PCR diagnostics and addressing critical healthcare challenges is truly inspiring.

👀 Stay tuned for updates as we evaluate these groundbreaking ideas!
• Shortlist Announcement: 4 March 2025
• Final Selections: 8 August 2025

🔗 Learn more: bit.ly/3AIYcX8

#Seegene #NatureAwards #MDxImpactGrants #MolecularDiagnostics

🚨 🤒 Norovirus = The leading cause of acute gastroenteritis during winter!
This virus spreads quickly through contaminated food, water, or direct contact for 2 weeks or more even after you feel better. If you experience symptoms like vomiting, abdominal pain, or diarrhea, an accurate diagnosis is essential for prompt action.

With Seegene’s diagnostic solutions, you can benefit from accurate and proper treatment. Don’t let this illness catch you off guard—prepare thoroughly and stay protected!
#Seegene #Gastroenteritis #Norovirus #NorovirusInfection #FoodPoisoning #WinterInfectiousDiseases

COVID-19, influenza, and respiratory syncytial virus (RSV) are three major viruses that pose significant challenges to global public health.

These viruses share key characteristics, including:
✔️ High transmissibility
✔️ Pandemic and seasonal epidemic potential
✔️ Similar symptoms

Since these viruses often circulate together during seasonal outbreaks, co-infection with multiple pathogens can lead to higher mortality rates.
Therefore, high-multiplex PCR testing is essential for detecting multiple pathogens simultaneously, ensuring timely treatment when it matters most.

#Globalhealth #Respiratoryinfection #Winterseason #Multidemic #Mortality #MDx

Seegene Technologies

About: